SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Luxembourg moves forward with bill for cannabis legalisation

    By
    Home / Luxembourg moves forward with bill for cannabis legalisation

    Luxembourg’s government has approved a bill that aims to establish the legal production and supply of cannabis.

    In a bid to move consumers away from the black market, Luxembourg is moving forward with plans to legalise recreational cannabis use.

    According to TRL Today, the government approved the bill last week, which is part of the government’s move to fight against substance addiction.

    Read more: Switzerland approves pilot for regulated cannabis sales

    In 2018, the Minister of State submitted plans to legalise the sale of recreational cannabis, drawn up by the Minister of Health, but delayed on the matter until 2021. 

    The country announced it would be putting forward a bill that would enable the production and sale of recreational cannabis, and would allow Luxembourg citizens to grow up to four cannabis plants in their home for personal use. 

    However, this would be limited to private residences only and consumption of cannabis in public will still be prohibited.

    The goal is to enable a national production and sales chain to be introduced under state control, with product quality assurance. 

    Previously, the government has noted that revenues from cannabis sales would be given priority into prevention, education and healthcare, and invested in the field of addiction.

    The introduction of the bill will see Luxembourg join countries such as Malta, Denmark and Switzerland – which last month announced the approval of a pilot in the City of Basel for regulated cannabis sales – in developing new and progressive approaches to national cannabis legislation. 

    Switzerland’s pilot is also a bid to move people away from the black market, as cannabis is the most consumed drug in the country.

    [activecampaign form=31]

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free